(Q54649529)

2 June 2018

title

Serotonergic dysfunction in women with pure premenstrual dysphoric disorder: is the fenfluramine challenge test still relevant? (English)

1 reference

2 June 2018

author name string

Steiner M

1

1 reference

2 June 2018

Yatham LN

2

1 reference

2 June 2018

Coote M

3

1 reference

2 June 2018

Wilkins A

4

1 reference

2 June 2018

Lepage P

5

1 reference

2 June 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

2 June 2018

published in

Psychiatry Research

1 reference

2 June 2018

volume

87

1 reference

2 June 2018

issue

2-3

1 reference

2 June 2018

page(s)

107-115

1 reference

2 June 2018

Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

The neuroendocrine response to d-fenfluramine in women with premenstrual depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Hormonal responses to d- and d,l-fenfluramine in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Recovery from major depression is not associated with normalization of serotonergic function.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Is platelet imipramine binding reduced in depression? A meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Inhibitory effect of ritanserin on the 5-hydroxytryptophan-mediated cortisol, ACTH and prolactin secretion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Hormone responses to fenfluramine and placebo challenge in endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Effects of age and gender on CNS serotonergic responsivity in normal adults

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Hormonal responses to fenfluramine in depressed and control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

D,L-fenfluramine challenge test: experience in nonpatient sample.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

d-Fenfluramine/prolactin response throughout the menstrual cycle: evidence for an oestrogen-induced alteration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Effect of pindolol on the prolactin response tod-denfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Evidence for 5-hydroxytryptamine1A receptor involvement in the control of prolactin secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Prolactin secretion in man: a useful tool to evaluate the activity of drugs on central 5-hydroxytryptaminergic neurones. Studies with fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Research diagnostic criteria: rationale and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Premenstrual syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Serotonin re-uptake inhibitors in the treatment of premenstrual dysphoria: Current state of knowledge

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Serotonergic function and late luteal phase dysphoric disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

Neuroendocrine probes of serotonergic function: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2899%2900062-1

7 January 2021

10.1016/S0165-1781(99)00062-1

Identifiers

DOI

1 reference

2 June 2018

1 reference

2 June 2018